Comparison Tool
Compare regulatory pathways side-by-side
Pick 2 or 3 countries to benchmark timelines, fees, requirements and supply pathways across MAHMAH, GMPGMP, HTAHTA and more.
Lead pathway (timeline & fees)
Pathway name
- πΊπΈUnited StatesNew Drug Application β 505(b)(1)
- πͺπΊEuropean UnionCentralised Procedure
- π¬π§United KingdomInternational Recognition Procedure (IRP)
Approval timeline
- πΊπΈUnited States304β365 days
- πͺπΊEuropean Union210β277 days
- π¬π§United Kingdom60β110 days
Application fee
- πΊπΈUnited StatesUSD 4,310,002
- πͺπΊEuropean UnionEUR 358,800
- π¬π§United KingdomGBP 35,305
Annual renewal
- πΊπΈUnited StatesUSD 416,734
- πͺπΊEuropean UnionEUR 122,500
- π¬π§United KingdomGBP 0
Local representative
- πΊπΈUnited StatesNot required
- πͺπΊEuropean UnionRequired
- π¬π§United KingdomNot required
Local manufacturing
- πΊπΈUnited StatesNot required
- πͺπΊEuropean UnionNot required
- π¬π§United KingdomNot required
GMP inspection
- πΊπΈUnited StatesRequired
- πͺπΊEuropean UnionRequired
- π¬π§United KingdomNot required
Unlock the full comparison
You're seeing a 2-section preview. Upgrade to Pro for accelerated pathways, MAHMAH requirements, post-approval, unlicensed routes, trials and pricing rows.